ACDIMA Center for Bioequivalence and Pharmaceutical Studies/ The Hashemite Kingdom of Jordan
ACDIMA Center for Bioequivalence and Pharmaceutical Studies was established in 2000 as a center that conducts bioavailability, bioequivalence, clinical, pharmacokinetics and pharmaceutical studies, as well as chemical analyses of biological samples. The financial outcomes indicate that the Center has generated a net profit of USD 258,122 in 2014, equivalent to KWD 73,565 as compared to 2013 profits estimated at USD 221,660, equivalent to KWD 63,173. Moreover, the Center has executed various bioequivalence studies in respect of various pharmaceutical products for a number of pharmaceutical factories and companies in the Arab and foreign Countries. The Center is now accredited by a number of Arab health authorities as a reference center for these studies. ACDIMA provided continuous support for this project through training, qualifying technical personnel and supplying modern equipment and supplies to the Center. The strategic plan of the Center›s development was adopted, and a clinical site was set up in the Center, and its analytical instruments were upgraded to comply with the set global standards in this context.